tiprankstipranks
Iterum Therapeutics (ITRMF)
OTHER OTC:ITRMF
US Market
ITRMF
Iterum Therapeutics
RESEARCH TOOLSreports
Want to see ITRMF full AI Analyst Report?

Iterum Therapeutics (ITRMF) Income Statement

957 Followers

Iterum Therapeutics Income Statement

Last quarter (Q3 2025), Iterum Therapeutics's total revenue was $390.00K, an increase of Infinity% from the same quarter last year. In Q3, Iterum Therapeutics's net income was $-8.98M. See Iterum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -254.00K$ -1.75M$ -1.80M$ -2.10M$ -161.00K
Operating Expenses
$ 18.44M$ 45.72M$ 28.58M$ 22.43M$ 31.96M
Depreciation and Amortization
$ 284.00K$ 1.75M$ 1.80M$ 2.10M$ 161.00K
EBITDA
$ -21.73M$ -34.58M$ -39.97M$ -83.20M$ -36.01M
Operating Income
$ -18.70M$ -47.47M$ -30.38M$ -24.54M$ -32.13M
Other Income/Expenses
$ -5.84M$ 9.71M$ -13.75M$ -66.32M$ -19.14M
Pretax Income
$ -24.53M$ -37.76M$ -44.13M$ -90.86M$ -51.26M
Net Income
$ -24.77M$ -38.37M$ -44.43M$ -91.56M$ -52.01M
Per Share Metrics
Basic EPS
$ -1.26$ -2.96$ -3.63$ -8.41$ -32.49
Diluted EPS
$ -1.26$ -2.96$ -3.63$ -8.41$ -32.49
Weighted Average Shares Outstanding
 19.70M 12.96M 12.24M 10.89M 24.01M
Weighted Average Shares Outstanding (Diluted)
 19.70M 12.96M 12.24M 10.89M 24.01M
Currency in USD

Iterum Therapeutics Earnings and Revenue History